# OnCo record jedd-wolchok (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/jedd-wolchok/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "jedd-wolchok" ;
  schema:name "Jedd D. Wolchok"@en ;
  schema:description "Led CheckMate 067, the trial whose ten-year data showed half of advanced melanoma patients on nivolumab plus ipilimumab are alive."@en ;
  schema:url <https://onco.cc/people/jedd-wolchok/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Wolchok%20JD%5BAuthor%5D%20melanoma%20ipilimumab%20nivolumab> ;
  onco:tag "melanoma", "immunotherapy", "trialist" ;
  schema:jobTitle "Meyer Director, Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine" ;
  schema:sameAs <https://orcid.org/0000-0001-6718-2222> ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/ctla4/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/ipilimumab/> ;
  onco:institutions <https://onco.cc/institutions/weill-cornell-meyer-cancer-center/> ;
  onco:trials <https://onco.cc/trials/checkmate-067/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-checkmate-067-10-year-nejm-2025/>, <https://onco.cc/key-papers/paper-hodi-ipilimumab-melanoma-nejm-2010/> ;
  schema:affiliation <https://onco.cc/institutions/weill-cornell-meyer-cancer-center/> .